论文部分内容阅读
从1960年以来按照祖国医学“活血化瘀”和“异病同治”的原则,用固定的活血化瘀方药“通脉灵”,对一些血管性疾病,如血栓闭塞性血管炎、脑血管疾病和冠心病等进行临床治疗,获得了较为满意的疗效。以上这些病因学上全然不同的疾病,其病变的共性是血液循环障碍,尤其是在这些疾病早期尚处于血管功能性障碍的阶段,病变特点是血管紧张性增加甚至痉挛,在这种情况下,活血化瘀药物的临床疗效尤为显著,这为实验室提出了深入研究活血化瘀药物作用原理的任务。我们从“通脉灵”注射液对
Since 1960, in accordance with the principle of “blood circulation and elimination of blood circulation” and “different diseases and the same treatment” in the motherland’s medicine, with a fixed recipe for promoting blood circulation and removing blood stasis, “Tong Mai Ling,” for some vascular diseases such as thromboangiitis obliterans and cerebrovascular diseases And coronary heart disease and other clinical treatment, obtained a more satisfactory effect. These etiologies are completely different diseases, and the common features of the lesions are blood circulation disorders, especially in the early stage of these diseases, which are still in the stage of vascular functional disorders. The lesions are characterized by increased vascular tone or even paralysis. In this case, The clinical efficacy of promoting blood circulation and removing blood stasis drugs is particularly significant, which gives the laboratory the task of studying the principle of action of blood circulation and stasis drugs. We from the “Tong Mai Ling” injection pair